Hugo A. Katus
Heidelberg University
1553 Papers
9.9K Citations
Hugo A. Katus is an academic researcher from Heidelberg University. The author has contributed to research in topics: Medicine & Myocardial infarction. The author has an hindex of 107, co-authored 1496 publications. Previous affiliations of Hugo A. Katus include University Hospital Heidelberg.
Chat about Author
Papers
Biomarker Concentrations and Their Temporal Changes in Patients With Myocardial Infarction and Nonobstructive Compared With Obstructive Coronary Arteries: Results From the PLATO Trial
Marcus Hjort,Kai M. Eggers,Tatevik Ghukasyan Lakic,Johan Lindbäck,Andrzej Budaj,Jan H. Cornel,Evangelos Giannitsis,Hugo A. Katus,Agneta Siegbahn,Robert F. Storey,Richard C. Becker,Lars Wallentin,Bertil Lindahl +12 more
TL;DR: In this article , a post hoc study of the PLATO (Platelet Inhibition and Patient Outcomes) trial, concentrations of hs-cTnT (high-sensitivity cardiac troponin T), NT-proBNP (N−terminal pro-B•type natriuretic peptide), hs−CRP (high−sensitivity C−reactive protein), and GDF‐15 (growth differentiation factor 15) were measured in patients with nonobstructive coronary arteries (MINOCA) at baseline and at 1-month follow-up (n=107).
17
High-sensitivity cardiac troponin T as an independent predictor of stroke in patients admitted to an emergency department with atrial fibrillation.
Mehrshad Vafaie,Evangelos Giannitsis,Matthias Mueller-Hennessen,Moritz Biener,Elena Makarenko,Buelent Yueksel,Hugo A. Katus,K M Stoyanov +7 more
TL;DR: Elevated hsTnT levels are significantly associated with higher risk of stroke and provide prognostic information independent of CHA2DS2-VASc score variables, which may improve prediction of stroke risk in patients presenting to an emergency department with AF.
Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin t in an unselected emergency department population
TL;DR: In this paper, the authors compared protocols of rising and falling absolute and relative cardiac troponin T (hs-cTnT) changes in an unselected emergency department population.
17
Inhibition of Histone Deacetylases Induces K+ Channel Remodeling and Action Potential Prolongation in HL-1 Atrial Cardiomyocytes.
Patrick Lugenbiel,Katharina Govorov,Ann-Kathrin Rahm,Teresa Wieder,Dominik Gramlich,Pascal Syren,Nadine Weiberg,Claudia Seyler,Claudia Seyler,Hugo A. Katus,Hugo A. Katus,Dierk Thomas,Dierk Thomas +12 more
TL;DR: The present findings link class I/II HDAC activity to regulation of ion channel expression and action potential duration in atrial cardiomyocytes and clinical implications for HDAC-based antiarrhythmic therapy and cardiac safety of HDAC inhibitors require further investigation.
Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation.
Ibrahim Gueler,Susanne Mueller,Matthias Helmschrott,Christian U. Oeing,Christian Erbel,Lutz Frankenstein,Christian Gleißner,Arjang Ruhparwar,Philipp Ehlermann,Thomas J. Dengler,Hugo A. Katus,Andreas O. Doesch +11 more
TL;DR: Vildagliptin therapy significantly reduced HbA1c and mean blood glucose levels in post-HTx patients in this study with T2DM and did not have any negative effects on lipid profile or body weight.